JAM
DAWN

Jupiter Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Jupiter Asset Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36,671
Closed -$535K – 452
2023
Q4 		$535K Buy
+36,671
New +$445K 0.01% 415

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jupiter Asset Management's DAWN Position: Q1 2024 in Review

Jupiter Asset Management sold out of Day One Biopharmaceuticals (DAWN) in Q1 2024, closing a stake of 36,671 shares — an estimated $535K sold.

Jupiter Asset Management first reported a position in DAWN in Q4 2023 and held it in 1 quarter. The position peaked at $535K in Q4 2023. 149 funds tracked by Wall St. Rank hold DAWN as of Q1 2024.

  • Jupiter Asset Management reported no remaining Day One Biopharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Jupiter Asset Management sold 36,671 Day One Biopharmaceuticals shares in Q1 2024, an estimated $535K.
  • Jupiter Asset Management first reported a position in Day One Biopharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Jupiter Asset Management's Day One Biopharmaceuticals position peaked at $535K in Q4 2023.
  • 149 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2024.

Based on Jupiter Asset Management's 13F filing for Q1 2024, filed 10 May 2024.